Randal A. Byrn

Designing CD4 immunoadhesins for AIDS therapy

Daniel J. Capon, Steven M. Chamow, Joyce Mordenti et al. · Nature · 1989 · 620 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

S Y Kim, Randal A. Byrn, Jerome E. Groopman et al. · Journal of Virology · 1989 · 577 citations · Full text

Life Sciences, Microbiology, Molecular Biology +14

Blocking of HIV-1 Infectivity by a Soluble, Secreted Form of the CD4 Antigen

Douglas H. Smith, Randal A. Byrn, Scot A. Marsters et al. · Science · 1987 · 484 citations

Life Sciences, Infectious Diseases, Molecular Biology +12

Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease

Robert B. Perni, Susan J. Almquist, Randal A. Byrn et al. · Antimicrobial Agents and Chemotherapy · 2006 · 387 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus.

R. Alan B. Ezekowitz, M Kuhlman, JE Groopman et al. · The Journal of Experimental Medicine · 1989 · 334 citations · Full text

Life Sciences, Biochemistry, Immunology +17